Last updated 2026-07-30
TL;DR
Enclomiphene is not birth control and doesn't prevent pregnancy in a partner. As a SERM, it raises LH, FSH, and testosterone while typically preserving sperm production and testicular size, unlike injectable testosterone, which usually shuts down sperm output. Enclomiphene isn't FDA-approved as a standalone drug; what's sold today is compounded, so quality and dosing consistency depend on the pharmacy.
Is enclomiphene a form of birth control?
No. Enclomiphene doesn't stop sperm production or prevent conception. If anything, it tends to push the reproductive system in the opposite direction, toward more sperm production, not less. Men sometimes search this phrase because they're confused about how a testosterone-related drug interacts with fertility, and the confusion is fair. Testosterone itself, taken as injections, gels, or pellets, functions almost like a male contraceptive at high enough doses because it shuts off the brain's signal (LH and FSH) to the testicles. Enclomiphene works through a completely different mechanism and doesn't carry that contraceptive-like side effect. If you or a partner need actual contraception, enclomiphene isn't it. Use a real method. This drug's whole appeal for many men is that it raises testosterone without imposing the fertility shutdown that comes with standard TRT.
How does enclomiphene affect fertility compared to TRT?
Enclomiphene is a selective estrogen receptor modulator (SERM). It blocks estrogen receptors in the hypothalamus, which tells the brain there isn't enough estrogen signal coming back, so the hypothalamus increases GnRH pulses. That drives the pituitary to release more LH and FSH, and those two hormones are what tell the testicles to make both testosterone and sperm [1]. That's the mechanical reason enclomiphene tends to preserve, and in some men improve, sperm parameters, while exogenous testosterone tends to suppress them. Exogenous TRT (injections, gels, pellets) adds testosterone from outside the body. The hypothalamus and pituitary sense plenty of testosterone already circulating and cut back GnRH, LH, and FSH accordingly. Without LH and FSH driving the testicles, intratesticular testosterone (which needs to be roughly 50 to 100 times higher than blood levels for sperm production) falls, and sperm counts drop. A well-known review in Translational Andrology and Urology and related literature has documented this for years, and it's why men on TRT alone often see azoospermia or severe oligospermia within three to six months [2]. Enclomiphene skips that problem because it never introduces outside testosterone. It raises the man's own production by working upstream. That's the central contrast this whole topic revolves around: same goal (higher T, symptom relief), opposite effect on the sperm-making machinery. None of this means enclomiphene works identically well for every man, or that fertility preservation is assured. Baseline sperm quality, age, and other conditions still matter, and nobody should assume normal fertility just because they switched from testosterone to enclomiphene.
Does enclomiphene actually preserve sperm count and testicular size?
The clinical data leans supportive but isn't as large or as long-term as most men would like. Clomiphene citrate, the older drug that contains both enclomiphene and its mirror-image isomer zuclomiphene, has decades of use in reproductive medicine, including for male infertility and as a post-TRT restart protocol, and multiple studies show it raises LH, FSH, and testosterone while maintaining or improving sperm parameters in men with low testosterone [3]. Enclomiphene-specific data is smaller. The compound went through Phase 2 and Phase 3 trials under the name Androxal in the 2010s. Those trials showed enclomiphene raised testosterone into the normal range while maintaining sperm counts and LH/FSH levels better than testosterone gel comparators in secondary hypogonadism [4]. Testicular size, which shrinks under TRT because the testicles stop being stimulated by LH, is generally maintained on enclomiphene because LH signaling continues. What's missing is a big, long-duration, published trial with semen analysis as a primary endpoint over a year or more. Most of the fertility-related data is a mix of the older clomiphene literature and secondary or pharmacokinetic analyses of the Androxal program. Men who want documented certainty about sperm counts before and after should get a baseline semen analysis and repeat it, more than trust the mechanism. For a broader look at what the trial and real-world data show, see enclomiphene success rate and the compiled patient experiences in enclomiphene reviews.
Why isn't enclomiphene FDA-approved, and what does that mean for buyers?
Enclomiphene was developed under the brand name Androxal by Repros Therapeutics specifically to treat secondary hypogonadism in men who wanted to preserve fertility. It went through FDA review more than once and did not get approved. The FDA's complete response letters raised concerns about the clinical trial data package, including questions about efficacy consistency and study design, not a specific safety signal that makes the drug dangerous [5]. Repros eventually stopped pursuing it, and no company currently holds an FDA-approved indication for standalone enclomiphene. What's sold today, including through Enclomiphene Direct and similar telehealth routes, is compounded enclomiphene. Compounded drugs are prepared by licensed pharmacies under section 503A or 503B of the Federal Food, Drug, and Cosmetic Act, not FDA-approved as finished products [6]. That's a real regulatory distinction, not a technicality. It means there's no FDA-reviewed label, no FDA-verified manufacturing consistency requirement of the kind branded drugs face, and quality depends heavily on which pharmacy compounds it. As the FDA states directly about this category, "Compounded drugs are not FDA-approved," and the agency does not verify their safety, effectiveness, or quality before they reach patients [6]. This doesn't mean the drug doesn't work or is unsafe by definition. Clomiphene citrate (which contains enclomiphene) has been FDA-approved since 1967 for female infertility, and enclomiphene itself has real Phase 3 human trial data behind it. But it does mean buyers should pick a compounding pharmacy that does third-party testing and treat any marketing claims about outcomes with real skepticism, especially anything promising a specific result up front.
What's the difference between enclomiphene and clomiphene (Clomid)?
Clomiphene citrate is a mixture of two isomers: enclomiphene (the trans-isomer) and zuclomiphene (the cis-isomer). Roughly 62% of clomiphene citrate by weight is enclomiphene and about 38% is zuclomiphene, though exact ratios can vary by batch and manufacturer [7]. These two isomers behave differently in the body. Enclomiphene has a short half-life (roughly 10 hours) and acts as a straightforward estrogen receptor antagonist at the hypothalamus, which is the desired effect for raising LH and FSH. Zuclomiphene has a much longer half-life, estimated at multiple days to over a week in some analyses, and it has some estrogen-agonist activity rather than pure antagonist activity [8]. It accumulates with repeated dosing because of that long half-life, and some researchers believe zuclomiphene buildup contributes to the mood-related side effects (irritability, visual disturbances, mood swings) that a subset of men report on long-term clomiphene use. Enclomiphene as a standalone compound removes zuclomiphene from the picture. In theory, that should mean fewer of the estrogenic side effects associated with zuclomiphene accumulation while keeping the LH/FSH-boosting benefit. That's the entire rationale behind Repros trying to develop and sell it separately in the first place. Whether it's clinically better tolerated than clomiphene over years of use hasn't been proven in large head-to-head trials; it's a reasonable pharmacological argument, not a settled outcome.
Do I still need contraception while taking enclomiphene?
Yes. Enclomiphene doesn't prevent pregnancy in a partner, and if your sperm parameters stay normal or improve, you may be just as fertile, or more fertile, than before starting treatment. Men who don't want to conceive should use standard contraception exactly as they would otherwise, condoms, a partner's contraceptive method, or vasectomy if that's the long-term plan. This is worth stating directly because some men conflate "my testosterone is being managed by a prescription" with some kind of fertility control. It isn't. If you're on enclomiphene specifically because you and a partner are trying to conceive, that's a different, more careful conversation to have with a reproductive endocrinologist or urologist, ideally with semen analysis tracking your baseline and progress.
Can enclomiphene help fertility in men trying to conceive?
This is where the evidence needs to be stated carefully, without overselling it. Clomiphene citrate has real use as a fertility treatment for men with low testosterone and impaired sperm production, and multiple studies and clinical reviews describe LH/FSH and testosterone increases alongside stable or improved sperm counts [3]. Enclomiphene, sharing the active mechanism, is reasonably expected to do something similar. But "reasonably expected" isn't the same as "proven to increase pregnancy rates." There is no large, enclomiphene-specific randomized trial showing improved live birth or conception rates in couples trying to conceive. Men using it for this reason should treat it as one tool alongside a fertility workup, not a fix with promised outcomes, and should be tracking semen analysis over time rather than assuming improvement. If infertility is the primary reason for treatment, a reproductive urologist who can order a full semen analysis, hormone panel, and possibly genetic testing is a better first stop than a testosterone-focused telehealth service alone.
What happens to testicular size and sperm count after stopping TRT vs. enclomiphene?
| Factor | Exogenous TRT | Enclomiphene | |
|---|---|---|---|
| LH/FSH levels | Suppressed, often to near-zero | Maintained or increased | |
| Sperm production | Often suppressed to oligospermia or azoospermia within 3-6 months | Generally maintained | |
| Testicular size | Often shrinks (testicles are no longer stimulated) | Generally maintained | |
| Recovery after stopping | Can take months to over a year; not guaranteed in all men | No suppression to recover from | |
| FDA approval status | Approved (multiple testosterone products) | Not approved standalone; compounded only | The mechanism explains the recovery gap. On TRT, once you stop, the hypothalamus and pituitary have to wake back up and start signaling again, and the testicles have to respond to that renewed signal after months of dormancy. That recovery isn't instant and isn't universal. Studies on post-TRT recovery of spermatogenesis show wide variability, with some men recovering within months and others taking over a year or not fully recovering, particularly with longer treatment duration or older age [2]. On enclomiphene, there's no suppression to recover from in the first place, because LH and FSH signaling never stopped. That's the practical, real-world version of the "preserves fertility" claim, and it's the reason many men considering TRT alternatives look at enclomiphene specifically when fertility matters to them now or in the near future. For a fuller before/after picture including timeframes, see enclomiphene before and after and enclomiphene results timeline. |
What are the side effects that might affect a decision around fertility and family planning?
The Androxal Phase 3 program and clomiphene literature both report a similar side effect profile: mood changes, headache, occasional visual disturbances, and estrogen-related symptoms like mild breast tenderness in some men [4]. These aren't fertility-specific side effects, but they matter to men weighing enclomiphene against TRT for family planning reasons, because tolerability affects whether someone actually stays on treatment long enough to matter. Blood work still needs monitoring. Estradiol, testosterone, LH, and FSH should be checked periodically, and a semen analysis is the only way to actually know what's happening to sperm count rather than assuming the mechanism guarantees a result. Nobody should skip that step and just trust the pharmacology.
How should I decide between enclomiphene and TRT if fertility matters to me?
If preserving the ability to conceive now or in the near future is a real priority, and your hypogonadism is secondary (a pituitary/hypothalamus signaling issue rather than primary testicular failure), enclomiphene is the more fertility-friendly starting point of the two, based on how each drug works [1][2]. If your hypogonadism is primary, meaning the testicles themselves aren't responding even with adequate LH/FSH signal, enclomiphene won't help as much because there's no signaling problem to fix, and TRT (with or without adjunct hCG for fertility support) may be the more realistic option regardless of fertility goals. This isn't a decision to make from a website. A urologist or endocrinologist who checks LH, FSH, testosterone, and ideally does a semen analysis before starting anything can tell you which category you're actually in. A comparison of the tradeoffs, cost, and what current users report is covered in enclomiphene pros and cons and is enclomiphene worth it, and Enclomiphene Direct's provider-reviewed intake process is built around checking those labs before prescribing anything, then routing the prescription to a licensed compounding pharmacy partner rather than compounding anything in-house.
Frequently asked questions
Does enclomiphene work as a male birth control pill?
No. Enclomiphene raises LH, FSH, and testosterone and generally maintains or supports sperm production rather than suppressing it. It has no contraceptive effect. If you need to prevent pregnancy, use a standard method; don't rely on enclomiphene for that purpose under any circumstance.
Can I get my partner pregnant while taking enclomiphene?
Yes, that's possible, and it's actually the point for many men who choose enclomiphene over TRT. Because it tends to preserve or improve sperm production rather than suppress it, fertility is generally maintained. If you're not trying to conceive, use contraception as you normally would.
Is enclomiphene FDA-approved?
No. Enclomiphene was developed as Androxal by Repros Therapeutics and went through FDA review but wasn't approved, due to concerns the FDA raised about the clinical trial data package. What's available today is compounded by licensed pharmacies under FDA rules for compounding (503A/503B), not sold as an FDA-approved finished drug.
What's the difference between enclomiphene and clomiphene (Clomid)?
Clomiphene citrate is a mix of two isomers, roughly 62% enclomiphene and 38% zuclomiphene. Enclomiphene is the isomer responsible for raising LH and FSH; zuclomiphene has a much longer half-life and different receptor activity, and is thought to contribute to some of clomiphene's mood-related side effects when it accumulates.
Does enclomiphene shrink the testicles like TRT can?
Generally no. Testicular shrinkage on TRT happens because exogenous testosterone suppresses LH, which stops stimulating the testicles. Enclomiphene raises LH instead of suppressing it, so testicular size is typically maintained. This hasn't been tracked in a large dedicated long-term trial, so individual results can vary.
How long does it take for sperm count to recover after stopping TRT?
It varies widely; some men see recovery within a few months, others take over a year, and full recovery isn't guaranteed for everyone, especially after long TRT duration or at older age. This is a major reason some men choose enclomiphene instead, since there's no suppression period to recover from.
Can enclomiphene actually improve fertility in men trying to conceive?
It may help in men with secondary hypogonadism, based on the mechanism and related clomiphene research, but there's no large enclomiphene-specific trial proving improved pregnancy or live birth rates. Men trying to conceive should combine it with a full fertility workup and semen analysis tracking, not treat it as a fix with promised outcomes.
Is compounded enclomiphene safe if it's not FDA-approved as a finished drug?
Compounded drugs are prepared by pharmacies licensed under FDA compounding rules (503A or 503B), which is different from FDA approval of a finished product. Safety depends heavily on the specific pharmacy's quality practices and testing. Choosing a pharmacy that does third-party potency and purity testing matters more than most buyers realize.
Does enclomiphene affect a woman's fertility or birth control?
Enclomiphene is studied and used in men. Clomiphene citrate, which contains enclomiphene, is FDA-approved for female infertility (ovulation induction), a completely different clinical use. Enclomiphene is not a female contraceptive or fertility drug in the form sold for men's testosterone treatment.
What labs should I get before starting enclomiphene if fertility matters to me?
At minimum, total and free testosterone, LH, FSH, and estradiol, plus a baseline semen analysis if fertility preservation or conception is a real goal. Repeating labs and semen analysis a few months in is the only reliable way to know what's actually happening, rather than assuming the mechanism guarantees an outcome.
Why did enclomiphene (Androxal) never get FDA approval?
Repros Therapeutics submitted enclomiphene for FDA review under the name Androxal and received complete response letters raising concerns about the clinical trial data package and efficacy consistency, not a specific safety red flag. The company eventually stopped pursuing approval, leaving compounded enclomiphene as the only current market option.
Is enclomiphene better than TRT for a man who wants kids later but not now?
For secondary hypogonadism, enclomiphene keeps the LH/FSH signal active, so there's no suppression to reverse when the time comes. TRT can suppress sperm production for months and recovery isn't guaranteed to be quick or complete. A urologist checking whether your case is secondary vs. primary hypogonadism should guide the actual decision.
Sources
- Endocrine Society, Clinical Practice Guideline: Testosterone Therapy in Men with Hypogonadism (Bhasin et al., J Clin Endocrinol Metab, 2018): LH and FSH from the pituitary drive testicular testosterone and sperm production, and this axis is the target of SERM therapy
- Patel, A.S. et al., Translational Andrology and Urology, 'Testosterone and fertility: does testosterone therapy adversely affect sperm production' (PMID 27141455): Exogenous testosterone suppresses LH/FSH and sperm production, with recovery timelines varying widely and not guaranteed
- Katz, D.J. et al., Fertility and Sterility, 'Outcomes of clomiphene citrate treatment in men with hypogonadism' (PMID 22321448): Clomiphene citrate raises LH, FSH, and testosterone while generally maintaining or improving sperm parameters in hypogonadal men
- Wiehle, R.D. et al., Journal of Sexual Medicine, 'Enclomiphene citrate stimulates testosterone production while preventing oligospermia' (PMID 23941336): Phase 3 enclomiphene (Androxal) trial data showing testosterone increases with maintained sperm counts versus testosterone gel
- U.S. Food and Drug Administration, Drugs@FDA database, search record for Androxal (enclomiphene citrate), Application Number 022435: Enclomiphene citrate (Androxal, application 022435) has no FDA approval on record as a standalone drug product
- U.S. Food and Drug Administration, 'Compounding and the FDA: Questions and Answers': Compounded drugs are prepared under FD&C Act 503A/503B rules and are not FDA-approved finished products
- DrugBank, Clomiphene entry, DB00882: Clomiphene citrate is a mixture of enclomiphene (trans-isomer) and zuclomiphene (cis-isomer) in roughly 62/38 proportion
- Mikkelson, T.J. et al., 'Single-dose pharmacokinetics of clomiphene citrate isomers in anovulatory females and normal males', J Clin Pharmacol (PMID 3711327): Zuclomiphene has a much longer half-life than enclomiphene and accumulates with repeated dosing, differing in receptor activity